Skip to main content
. 2005 Sep;54(9):1217–1223. doi: 10.1136/gut.2004.059998

Figure 1.

Figure 1

 Peripheral blood mononuclear cell (PBMC) interferon γ (IFN-γ) ELISPOT dose-response relationship for individual coeliac disease subjects to A-gliadin p57–73 QE65 (n = 8) (A) and chymotrypsin digested gliadin with or without deamidation by tissue transglutaminase (tTG), and tTG alone (n = 5) (B). Results are expressed as per cent of an individual’s maximal response to any concentration of p57–73 QE65 or tTG-gliadin, respectively.